GE HealthCare is exhibiting more than 40 new innovations during the Radiological Society of North America’s (RSNA) Annual Meeting in Chicago, 26-30 November 2023.
The range of innovations aim to address radiologist shortages, mounting workloads and lack of access to (MRI)s.
Devices demonstrated at the event includes the SIGNA Champion, a 1.5T scanner which has AI supported workflows and technologies like, Sonic DL, AIR Coils and AIR Recon DL which GE HealthCare claims can reduce scan times by 50%.
The company recently launched the latest version of its Digital Expert Access (DEA), a US Food and Drug Administration (FDA) 510(k) cleared device which supports remote patient scanning.
On top of the releases, GE HealthCare shared its developments in ultra sound imaging highlighting Venue Family point-of-care ultrasound systems, an AI technology delivering real-time guidance capturing diagnostic-quality cardiac images and LOGIQ E10 Series, featuring Verisound Digital & AI Solutions. These developments in ultrasound imaging come on the back of a September grant of $44 million from the Bill & Melinda Gates Foundation
According to the Association of American Medical Colleges (AAMC) there could be a shortage of almost 42,000 radiologists in the United States in 2033. A 2022 survey of 13,000 US physicians showed that 49% percent of radiologist felt burnt out. And with an ageing global population these figures are expected to increase.
On November 10, GE HealthCare and radiology imaging diagnostic application Sectra joined forces to address these increasing workloads by utilising each other’s technology.
Peter Arduini, CEO of GE HealthCare outlined the company’s goal for addressing burn out. He said: “Through our smart devices, streamlined disease state focus, and digital solutions, we’re bringing data together in the right place at the right time for providers, solving for inefficiencies in workflow, enabling precision care, and helping improve patient outcomes.”
The global MRI device market is estimated to reach $10bn by 2033, doubling from $5bn in 2022, according to a market model by GlobalData. Currently GE HealthCare owns a 29.3% global market share, according to the model.
